Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Akermin logo — Pioneering Next-Gen Biofuel Cells and Enzyme Applications fo...

Akermin

Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries

Founded 2003 Grant Total: $25.48M Biotechnology, Health Care +3

General Information

Company Name Akermin
Founded Year 2003
Industries Biotechnology, Health Care, IT +2
Funding Stage Grant
Social

Get notified when Akermin moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Akermin

Akermin, established in 2004 in St. Louis, Missouri, is "Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries" as per their slogan. The company's main focus is on commercial applications in wireless sensors and military uses, utilizing innovative stabilized enzyme technology created at Saint Louis University. Akermin showcased a prototype biofuel cell by 2008 that operates on methanol fuel and uses stabilized laccase as a replacement for the metal catalyst in traditional cathodes. The development of stabilized enzymes for use in the food processing, biofuels, chemical, and pharmaceutical industries is also underway. The company operates within the Biotechnology, Health Care, IT, Manufacturing, Autonomous, and Sensor Tech industries. Akermin received a $3.00M grant investment on 21 October 2013. The investors for this last investment are currently undisclosed.

Taxonomy: Biofuel Cells, Enzyme Applications, Stabilized Enzyme Technology, Methanol Fuel, Laccase, Wireless Sensors, Military Applications, Food Processing, Biofuels Industry, Chemical Industry, Pharmaceutical Industry, Saint Louis University, Innovative Technology, Commercialization, Prototype Development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 21 Oct 2013
Debt Financing •••••• - 08 Aug 2013
Venture Round •••••• 3
Investor Investor Investor
19 Feb 2013
Venture Round •••••• - 05 Jan 2011
Series B •••••• 5
Investor Investor Investor Investor
•••• •••• 		26 Jan 2010

View All 9 Funding Rounds

Akermin Alternatives & Competitors

Akermin vs
Enzymit
Enzymit Israel

Making cell-free bioproduction faster, simpler, cost-effective and sustainable

Series A
26 employees
Biotechnology, Health and Wellness
Akermin vs
Enzyme Supplies Limited
Enzyme Supplies Limited United Kingdom

World-class enzymes for biofuels, food processing, paper & pulp to brewing and baking. Reliable sinc...

2 employees
Biotechnology, Retail
Akermin vs
Okane Capital
Okane Capital Chile

Real-time liquidity provider for digital assets

10 employees
Trading Platform

FAQ About Akermin

Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries
Akermin was founded in 2003.
Akermin operates in the following industries: Biotechnology, Health Care, IT, Manufacturing, Autonomous and Sensor Tech.
Akermin has completed 9 funding rounds, raising a total of $25.48M. The latest funding stage is Grant.
Top alternatives and competitors to Akermin include Enzymit, Enzyme Supplies Limited, Okane Capital, Biomatter, Cocoon Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akermin and Enzymit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Akermin and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy